Publicacions en què col·labora amb Jordi Alberch Vié (7)

2011

  1. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease

    Brain, Vol. 134, Núm. 1, pp. 119-136

2010

  1. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum

    Cell Death and Differentiation, Vol. 17, Núm. 2, pp. 324-335

2009

  1. Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration

    FASEB Journal, Vol. 23, Núm. 6, pp. 1893-1906

  2. Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: Role in excitotoxicity

    Neurobiology of Disease, Vol. 36, Núm. 3, pp. 461-469

2007

  1. BH3-only proteins Bid and BimEL are differentially involved in neuronal dysfunction in mouse models of Huntington's disease

    Journal of Neuroscience Research

2006

  1. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain

    European Journal of Neuroscience, Vol. 23, Núm. 3, pp. 649-658

2005

  1. Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease

    Journal of Neuroscience, Vol. 25, Núm. 42, pp. 9773-9781